Covance
Covance Inc. (Template:Nyse), formerly Hazleton Laboratories America, Inc., with headquarters in Princeton, New Jersey, provides drug development and animal testing services. According to its website, it is one of the largest companies of its kind in the world, with annual revenues of over $1 billion, operations in 20 countries, and over 8,000 employees worldwide. It provides the world's largest central laboratory network, and employs a global team of clinical trial professionals and cardiac safety experts. It became a publicly traded company after being spun off by Corning, Inc. in 1997.
Under the name Covance Research Products Inc. (CRP), based in Denver, Pennsylvania, the company also deals in the import and sale of laboratory animals. It is the single largest importer of primates in the U.S. and the world's largest breeder of laboratory dogs. It owns two dog-breeding facilities, two primate centers, and a rabbit-breeding facility.
The company has been the subject of controversy following allegations of primate abuse in its laboratories in Germany and the United States, and in connection with a potential outbreak of the Ebola virus.

# History of Covance
In the late 1980s and early 1990s, Corning Incorporated acquired numerous best-of-class drug development companies, some with roots dating back to the 1940s. In January 1997, Corning spun off these businesses as one publicly traded, independent company called Covance Inc..
The company's primary focus is serving the pharmaceutical and biotech industries. It provides testing services to the environmental, food, and nutritional supplement industries, and provides custom antibody products and services to the research community for neurological disorders. It also offers cell type-specific marker antibodies for neuroscience; suites of products for both Alzheimers and Parkinsons disease; and an online antibody store including phospho-specific and secondary antibodies.

# Ebola virus
In October 1989, 100 cynomolgus macaques (Macaca fascicularis) were imported from Mindanao Island in the Philippines through Amsterdam and New York to Hazleton Research Products' (now Covance), Primate Quarantine Unit in Reston, Virginia. A second shipment from the same supplier arrived on November 8. Shortly afterwards, some of the monkeys were found to have carried the Ebola.
In January 1990, the same Philippines supplier sent a shipment of 100 macaques to Hazleton's Texas Primate Center in Alice, Texas and another 100 Hazleton's Reston Unit. Between February 1 and March 15, 46 of 52 monkeys in one of the quarantine rooms died, showing the same symptoms as before. The Centers for Disease Control decided the monkeys were infected with simian hemorrhagic fever and Ebola.
In March 1996, 100 macaques from the same supplier were shipped to Hazleton in Alice, Texas. Two monkeys tested positive for the Ebola virus.

# Alleged primate abuse

## Munster, Germany
In 2004, German journalist Friedrich Mulln, working undercover at the German Covance facility in Munster, Europe's largest primate-testing center, obtained photographs, video, and other evidence of alleged abuse of monkeys and other non-human primates. The laboratory in Munster specializes in reproduction toxicology and primate toxicology, which includes testing on pregnant primates. The company is responsible for around half the primate experiments in Germany.
The undercover footage shows staff making monkeys dance in time to blaring pop music, handling them roughly, and screaming at them. The monkeys are shown isolated in small wire cages with little or no natural light and no environmental enrichment, and living with high noise levels caused by staff shouting and playing the radio.
Primatologist Dr. Jane Goodall described the living conditions of the monkeys as "horrendous," and told the British Union for the Abolition of Vivisection (BUAV) that to see them "crazed with boredom, and sadness probably, is deeply, deeply disturbing." Primatologist Stephen Brend told BUAV that using monkeys in such a stressed state is "bad science" and that trying to extrapolate useful data in such circumstances is an "untenable proposition."
The ensuing publicity in Germany gave rise to the "Close Covance" (Covance Schliessen) animal rights campaign there, as well as campaigns launched in Britain by the BUAV, and in America by PETA.
According to the European Biomedical Research Association, the local authorities in Munster inspected Covance after the video footage was shown on German television, and insisted that Covance install video cameras to monitor staff working with primates. Covance appealed through the courts, which decided that video monitoring would infringe the rights of the staff. The public prosecutor's office also viewed the film and questioned witnesses. The prosecutor's office concluded that Covance "had not rendered themselves liable to prosecution," thus clearing Covance of all charges. Covance maintains that the editing of the footage exaggerated the evidence.
After parts of Mulln's footage were shown on German television and in major newspapers, Covance filed a lawsuit, leading a German court to forbid further distribution of the material. The publication ban led to major protests from animal-rights advocates and anti-censorship activists. A first ruling confirming Covance's claims was partially reverted by a higher court's ruling that the right of the public to be informed on the subject prevailed over the company's privacy rights. The video footage may now be displayed publicly, albeit not in the form of the existing television edition, but it may not be used by animal-rights groups.

## Vienna, Virginia
People for the Ethical Treatment of Animals (PETA) found similar conditions in Covance's Vienna, Virginia lab during an undercover investigation in 2004-5.
A former study director at the Covance facility in Vienna, Virginia in the U.S., who worked there from 2002 to 2004, told city officials in Chandler, Arizona, that Covance was dissecting monkeys in its Vienna laboratory while the animals were still alive and able to feel pain.
The allegations were uncovered as part of an open-records request made by PETA in November 2006. The employee had earlier approached the city with her concerns when she learned that Covance planned to build a new laboratory in Chandler. 
She alleged that three monkeys in the Vienna laboratory had pushed themselves up on their elbows and had gasped for breath after their eyes had been removed, and while their intestines were being removed during necropsies. When she expressed concern at the next study directors' meeting, the employee says she was told that it was just a reflex. She told city officials that she believed such movements were not reflexes but suggested "botched euthanasia performed by inadequately trained personnel." She says that she was ridiculed and subjected to thinly veiled threats when she contacted her supervisors about the issue.
In June 2005, Covance filed a lawsuit against PETA and its former employee for fraud, breach of employee contract, and "conspiracy to harm the company's business by deceitfully infiltrating and videotaping the company's Vienna, Virginia facility."  Covance and PETA agreed to a settlement in which PETA accepted a five-year ban on any attempts to infiltrate Covance facilities. 
In a March 2006 statement, Covance announced that inspections of the Vienna, Virginia facility by the Food & Drug Administration (FDA) resulted in no findings to substantiate any claims made against the facility. Inspections by the United States Department of Agriculture (USDA) resulted in sixteen citations ranging, according to Covance, from "administrative issues to scope of veterinary authority." The company agreed to pay a settlement of $8,720. 

# Expansion
In recent years, Covance continued its expansion with acquisitions of drug development companies. Notably, in August 2005, Covance acquired GFI Clinical Services, an 80-bed clinical pharmacology business, from West Pharmaceutical Services, Inc. in order to expand the companys Phase I clinical research offerings. 
In May 2006, Covance also acquired Signet Laboratories, Inc., which is a provider of monoclonal antibodies used in the research of cancer, infectious disease and neurodegenerative disease.